USADA announced today that Bharat Vijay Kandare, of Maharashtra, India, has accepted a two-year sanction for a violation of the UFC® Anti-Doping Policy after testing positive for prohibited substances.
Kandare, 31, tested positive for exogenous boldenone and its metabolites, as well as a metabolite of tamoxifen, following an out-of-competition test conducted on July 23, 2018. Boldenone is a non-Specified Substance in the class of Anabolic Agents and tamoxifen is a Specified Substance in the class of Hormone and Metabolic Modulators. Both substances are prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.
“The goal of the UFC Anti-Doping Program is to deter the use of performance-enhancing drugs and this necessarily means we will identify and hold accountable those who use performance-enhancing substances to gain an advantage in the Octagon,” said USADA CEO Travis T. Tygart. “As the Program continues to grow and innovate, we will do our best to continue to protect clean athletes so that athletes can win in the Octagon without cheating and endangering their health and safety and that of their competitors.”
Kandares’s two-year period of ineligibility began on November 2, 2018, the date on which he was provisionally suspended from competition.
Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to continue to make themselves available for testing to receive credit for time completed under their sanction.